Alvarez & Marsal: Healthcare Industry Group

In Part II of our podcast, the discussion continues and dives into the impact of COVID-19 on patient volume, specifically as it relates to health system affiliated medical groups, telehealth usage, cash flow and distribution networks.

In this podcast, Health System leaders from across the country share their firsthand experience with the dynamic shifts in patient volume throughout the pandemic and what additional changes they anticipate in the short term, as well as their vision for the future.

In this 3-part series, you will hear insights from healthcare experts and government insiders on major administration initiatives, policy outlook and changes that the U.S. healthcare system may anticipate as the Biden administration steps in.

Part II: President Biden’s COVID-19 Plan, Campaign Promises Around Healthcare and What’s to Come for Prescription Drug Pricing In this 3-part series, you will hear insights from healthcare experts and government insiders on major administration initiatives, policy outlook and changes that the U.S. healthcare system may anticipate as the Biden administration steps in.

Part I: A look at HHS, the Latest COVID-19 Relief Bill and What the Next Two Years Means for Democrats and Republicans In this 3-part series, you will hear insights from healthcare experts and government insiders on major administration initiatives, policy outlook and changes that the U.S. healthcare system may anticipate as the Biden administration steps in.

Join A&M Managing Director, Debra Richman, as she talks with Marcus Osborne, SVP, Health & Wellness at Walmart to discuss healthcare strategy, the growth of retail health, and the role Walmart is playing in response to the COVID-19 crisis and the national roll out of vaccines.

As the largest vaccine rollout in modern history is underway across the country, A&M Managing Director Larry Kaiser moderates a conversation of experts who share their insights about what they are seeing in their organizations and elsewhere. Our panel also discusses the legality of employer vaccine mandates and how education and incentives are being utilized to help encourage vaccination.

A&M Healthcare Industry Group Managing Director, Michael Niarchos, moderates a conversation on the emerging trends in the Pharmacy and PBM ecosystem. Joined by Ryan Czado, Vice President and Director of Pharmacy Solutions at Lockton Companies, the two explore how various healthcare stakeholders are adapting to address these emerging trends. They also discuss the evolving nature of employer pharmacy benefit needs and how organizations are revising their strategies to manage the pharmacy benefit in an attempt to improve outcomes and manage costs.

In Part II of The Impact of COVID-19 on Cybersecurity Across the Healthcare Industry, A&M Managing Directors, Ken Barrette and Rocco Grillo, and Senior Directors Aaron Eichorn and Ian Donner discuss what Healthcare organizations should be focusing on now to adapt their cybersecurity strategies to the new normal. They will cover lessons learned from the pandemic and share how organizations should best move forward to protect against cyber threats.

Regulatory and Market Considerations of Recent Part D Rebate Regulations by Alvarez & Marsal